FoxO maintains a genuine muscle stem-cell quiescent state until geriatric age

Laura García-Prat,Eusebio Perdiguero,Sonia Alonso-Martín,Stefania Dell'Orso,Srikanth Ravichandran,Stephen R Brooks,Aster H Juan,Silvia Campanario,Kan Jiang,Xiaotong Hong,Laura Ortet,Vanessa Ruiz-Bonilla,Marta Flández,Victoria Moiseeva,Elena Rebollo,Mercè Jardí,Hong-Wei Sun,Antonio Musarò,Marco Sandri,Antonio Del Sol,Vittorio Sartorelli,Pura Muñoz-Cánoves
DOI: https://doi.org/10.1038/s41556-020-00593-7
Abstract:Tissue regeneration declines with ageing but little is known about whether this arises from changes in stem-cell heterogeneity. Here, in homeostatic skeletal muscle, we identify two quiescent stem-cell states distinguished by relative CD34 expression: CD34High, with stemness properties (genuine state), and CD34Low, committed to myogenic differentiation (primed state). The genuine-quiescent state is unexpectedly preserved into later life, succumbing only in extreme old age due to the acquisition of primed-state traits. Niche-derived IGF1-dependent Akt activation debilitates the genuine stem-cell state by imposing primed-state features via FoxO inhibition. Interventions to neutralize Akt and promote FoxO activity drive a primed-to-genuine state conversion, whereas FoxO inactivation deteriorates the genuine state at a young age, causing regenerative failure of muscle, as occurs in geriatric mice. These findings reveal transcriptional determinants of stem-cell heterogeneity that resist ageing more than previously anticipated and are only lost in extreme old age, with implications for the repair of geriatric muscle.
What problem does this paper attempt to address?